The potential of metabolomics in assessing global compositional changes resulting from the application of CRISPR/Cas9 technologies. (2023)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/s11248-023-00347-9

PubMed Identifier: 37166587

Publication URI: http://europepmc.org/abstract/MED/37166587

Type: Journal Article/Review

Volume: 32

Parent Publication: Transgenic research

Issue: 4

ISSN: 0962-8819